Across TCGA pan-cancer cohorts, CICP17 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of CICP17’s most consistent transcriptional readouts.

The strongest signal is observed in cholangiocarcinoma (CHOL), where CICP17 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CICP17 is over-expressed in tumor.

CHOL and KIRC are the cancer types where CICP17 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CICP17 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
CHOL	All	All	+0.017	.022	2	view →
KIRC	All	All	+0.007	.029	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: CICP17 RNA expression & survival · all CICP17 data types